Moderna的动态

Are you keeping up with KCR news? KCR Chief Medical Officer, Anna Baran, Principal Consultant, Dave Li, and Associate Consultant, Edyta Dzia?o were featured in European Pharmaceutical Review earlier this year with their article, "Delivery systems for Biologics." The article highlights the needs for balancing #safety, effectiveness, #cost in the delivery systems for biologics. Check out the #WhitePaper here: #KCRCRO #ClinicalTrials #ClinicalResearch #Innovation #DeliverySystems #whitepaper

?? Exciting advancements in European pharmaceutical research! ?? From groundbreaking treatments to innovative technologies, the pharma landscape in Europe is rapidly evolving. Stay tuned for the latest updates! ???? #PharmaResearch #Innovation #EuropePharma

#Biopharmaceutical_Logistic Market Expansion Projected to Gain an Uptick During 2023-2032 https://lnkd.in/dXeTQmw4 The spurring demand for #biopharmaceutical products, including vaccines, biologics, and other temperature-sensitive medications, is driving the growth of the biopharmaceutical #logistics market. The stringent regulatory standards for biopharmaceuticals' storage, transportation, and distribution also propel the #demand for advanced logistic services. C.H. Robinson Worldwide GmbH DB Schenker Deutsche Post und DHL UPS XPO Kuehne & Nagel International

What does it mean to be "patient-centric" in today's pharmaceutical industry? What actions are companies taking, and what technologies are they using to help? This Pharmaceutical Online podcast with Nanoform COO Christian Jones offers answers. #pharmaindustry #pharmaceuticalindustry #patientcentric https://lnkd.in/eKWSV2uC

Now we’re underway! The first participants have been dosed in our Phase 2a study. Among the six clinics across Sweden, Denmark, and the Netherlands, it was Stockholm and Gothenburg who were the first ones out. We are now entering an intensive period of ongoing recruitment, and the ones participating will receive doses for three consecutive days and then be monitored during eight weeks to evaluate efficacy and safety. #clinicaltrials #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #l?kemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutl?sning

The US is an utterly important market for us. We have now started interacting with FDA and just completed a pre-IND meeting receiving positive feedback on our development program for LIB-01. This is an important step towards including US study centers in future clinical studies. An early interaction with FDA is considered valuable to reach a consensus and ultimately secure market approval in the United States. "The FDA response shows that we are on the right track in our efforts to create a best-in-class drug in erectile dysfunction. It is also a quality mark for our development work that adds weight in discussions with potential pharmaceutical partners", comments Elin. Read the press release here: https://lnkd.in/dx7z5kAF #dicotnytt #pharma #pharmaceutical #drugdevelopment? #sexualdysfunctions #erectiledysfunction #prematureejaculation? #lifescience #kliniskastudier #l?kemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutl?sning

FDA Seeks Input on its Innovative Manufacturing Technology Strategy The US FDA this week released a draft of its strategic plan to promote the uptake of innovative manufacturing technologies for drugs and biologics. The plan fulfills a mandate of the Prescription Drug User Fee Act (PDUFA) Reauthorization Performance Goals for Fiscal Years 2023-2027 (PDUFA VII) to advance the implementation of innovative manufacturing. It was prompted by the feedback the agency received at its June 8, 2023 public meeting on the use of innovative manufacturing technologies for products regulated by the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER), as well as the barriers impeding their adoption. https://lnkd.in/g4nwXMmD #aspenalert #biotech #bioprocess

How successful are #AI-discovered drugs in clinical trials? In Phase I trials, #AI-discovered molecules are substantially more successful than historic industry averages. #Source : https://lnkd.in/e4TqS295 The success of #AI-discovered molecules in clinical trials so far. The analysis includes molecules that were partnered with pharmaceutical companies and excludes COVID-19-related molecules.?(a)?Clinical success of AI-discovered molecules by clinical Phase.?(b)?AI-discovered molecules that have completed Phase I trial, by mode-of-discovery. #AI #Pharmaceutical

We have just completed the recruitment to the final part of our phase 1 study and we are good to go. Results are expected in quarter two. "The fact that the last MAD participant has been enrolled is another important milestone we can tick off. Our collaboration with the CRO partner CTC is exemplary, greatly assisting us in constantly being on schedule", Elin comments. #clinicaltrials?#pharma?#pharmaceutical?#drugdevelopment?#sexualdysfunctions?#erectiledysfunction?#prematureejaculation?#lifescience?#kliniskastudier?#l?kemedelsutveckling?#sexuelladysfunktioner?#erektionssvikt?#tidigutl?sning

We have changed our company name. Let us introduce Dicot Pharma! -We are gradually expanding into a larger pharmaceutical company as our results from clinical studies emerge. Strengthening and internationalizing profiling is part of that expansion. The addition "Pharma" is logical and will support us in this process, Elin comments. Read the press release here: https://lnkd.in/dk36hWn7 #clinicaltrials #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #l?kemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutl?sning